Valeur, Eric,Golding, Bernard Thomas,Noble, Martin,Riedinger, Christiane,Hardcastle, Ian Robert,Watson, Anna Frances,Griffin, Roger John
申请号：
AU2009263974
公开号：
AU2009263974B2
申请日:
2009.06.25
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
